Overview The News Flow Neuroscience has launched FL-100 in the US, giving clinicians a new at-home treatment option for adults aged 18 and older with moderate to severe major depressive disorder who a...
Overview The News Big Health has raised $23.7M in a strategic funding round co-led by .406 Ventures and AlleyCorp, with participation from CVS Health Ventures, Blue Venture Fund, Sand...
